General Information
Revision date
2021-12-08
Product name
Arformoterol Tartrate Inhalation Solution
Manufacturer Name
The Ritedose Corporation
Icons in SDS
Company Information
company name
The Ritedose Corporation
Section 2
SECTION 2: Hazards identification
Fire and Explosion Expected to be non-combustible. Health Arformoterol tartrate inhalation solution is contraindicated in patients with a history of hypersensitivity to arformoterol, racemic formoterol or to any other components of this product. Use of a LABA, including arformoterol tartrate inhalation solution, without an inhaled cortisteroid is contraindicated in patients with asthma. Arformoterol tartrate inhalation solution is not indicated for the treatment of asthma.
Environmental hazards
No information is available about the potential of this product to produce adverse environmental effects.
